News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.
NewStem is developing a technology that uses human haploid embryonic stem cells to predict cancer drug resistance.
As Dana-Farber migrates its dozens of medical and radiation oncology protocols to the Philips platform, its focus is on digital pathology, genomics, and informatics.
Through the deal, Precision Therapeutics will acquire the 75 percent stake in Helomics that it does not already own.
The company will work with medical faculties of the universities of Greifswald and Rostock to develop Dx tools for personalized, immune-based treatments.
The companies will jointly offer pathology and molecular testing services to PPD's pharmaceutical and biotechnology customers.
